PBS News Hour

AstraZeneca scrambles to address concerns about vaccine data

AstraZeneca is facing new questions today after a highly unusual reprimand from a board overseeing the company’s clinical vaccine trials.The company is scrambling to respond to allegations that it used misleading data when claiming its vaccine was 79 percent effective against COVID-19 symptoms. Nick Schifrin breaks down the latest with epidemiologist Dr. Jennifer Nuzzo of Johns Hopkins University.

AstraZeneca scrambles to address concerns about vaccine data

6m 26s

WETA Passport

Stream tens of thousands of hours of your PBS and local favorites with WETA Passport whenever and wherever you want. Catch up on a single episode or binge-watch full seasons before they air on TV.